Amarin Corporation plc - American Depositary Receipt (AMRN)

Market Open

3 Mar, 14:51

NASDAQ (CM)

13. 69

-0.24

-1.72%

285.42M Market Cap

- P/E Ratio

- Div Yield

0 Volume

- Eps

$ 13.93

Previous Close

Day Range

13.66 13.94

Year Range

7 20.9

Want to track AMRN and more in your Portfolio? 🎯

Get Started For Free

AMRN earnings report is expected in 8 days (11 Mar 2026)

Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss

AMRN swings to Q4 profit and beats estimates, but revenues decline 21% as Vascepa sales slide and shares fall 9% on the mixed results.

Zacks | 4 days ago

Amarin Corporation plc (AMRN) Q4 2025 Earnings Call Transcript

Seekingalpha | 5 days ago

AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations

AMRN jumps 17% after Q4 and FY2025 preliminary sales beat expectations. The release also reflected positive Q4 cash flow and progress on cost cuts.

Zacks | 1 month ago

Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down

AMRN's third-quarter earnings fall short of expectations, but stronger U.S. Vascepa sales push revenues above estimates.

Zacks | 4 months ago

Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript

Amarin Corporation plc ( AMRN ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Aaron Berg - CEO, President & Director Peter Fishman - Senior VP & CFO Conference Call Participants Jessica Fye - JPMorgan Chase & Co, Research Division Mazahir Alimohamed - Leerink Partners LLC, Research Division Presentation Operator Welcome to Amarin Corporation's conference call to discuss its third quarter 2025 financial results. I would like to turn the conference call over to Bob Burrows, Investor Relations for Amarin.

Seekingalpha | 4 months ago

Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?

Amarin (AMRN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 4 months ago

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Here is how Amarin (AMRN) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

Zacks | 6 months ago

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Amarin (AMRN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks | 6 months ago